Scilex Holding Co. (SCLX)
15.76
-0.76
(-4.60%)
USD |
NASDAQ |
Dec 16, 16:00
15.70
-0.06
(-0.38%)
After-Hours: 20:00
Scilex EPS Diluted (Quarterly): -22.17 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Travere Therapeutics, Inc. | 0.2505 |
| Xenetic Biosciences, Inc. | -0.3307 |
| KalVista Pharmaceuticals, Inc. | -0.9183 |
| BeyondSpring, Inc. | -0.0382 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -257.82M |
| Revenue (Quarterly) | 10.56M |
| Total Expenses (Quarterly) | 267.79M |
| Enterprise Value | 160.57M |
| Gross Profit Margin (Quarterly) | 58.80% |
| Profit Margin (Quarterly) | -2.44K% |
| Earnings Yield | -209.9% |
| Normalized Earnings Yield | -196.16 |